Yes, the problem appears to be, although we
are paying much more than peanuts, we still
have monkeys running the show. Once again
with this bio tech management we have had
grossly exaggerated optimistic timelines. A few
years ago man. was talking as early as 2023
for regulatory approval. Now on this forum
we are talking 2026-2028. No wonder investors
are heading for the hills.
And where are Bell Potters ringing endorsements
lately.
Why are people selling?, page-23
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.010(4.55%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 22.8¢ | 23.3¢ | 22.5¢ | $46.92K | 203.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 337 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 138166 | 5 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |